Work

Supplementary Figure 1 from CD4+ T Cells Mediate MHC-Deficient Tumor Rejection and Endothelial Cell Reprogramming

Year: 2026

Type: supplementary-materials

Abstract: Supplementary Figure 1. Anti-CD40/ICB immunotherapy slows tumor growth in a CD4+ T cell-dependent, but CD8+ T cell- and NK1.1 cell-independent manner.

DOI: 10.1158/2326-6066.31024062

Authors: Samuel I. Kim, Margaret E. Haerr, Maryam Al-Ghezi, Canping Chen, Yi Zhang, Jackie L. Phipps, Charu Arora, Kyle P. Gribbin, Gangmin Kim, Nune Markosyan, Zheng Xia, Robert H. Vonderheide, Katelyn T. Byrne

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7119103882

Cites:

Cited by:

Related to: 10